IMMUPHARMA FRANCE SA;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
发明人:
Robert H. Zimmer,Fanny Valleix,Sylviane Muller
申请号：
US16400996
公开号：
US20190352341A1
申请日:
2019.05.01
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to modified peptides, and their use for treating a lupus-related auto-immune or inflammatory disorder, e.g., systemic lupus erythematosus (SLE or “lupus”).
